Pear Therapeutics and Crossroads Treatment Centers to Provide More Patients Access to Prescription Digital Therapeutics as Standard of Care for the Treatment of Substance Use Disorders

BOSTON--(BUSINESS WIRE)--Dec 15, 2021--

Related Keywords

Pennsylvania ,United States ,Virginia ,New Jersey ,Massachusetts ,Kentucky ,America ,Keely Boyer ,Karren Williams ,Ba Fulton Velez ,Robert Gerwien ,Weijia Wang ,Meara Murphy ,Warrenk Bickel ,Kirstin Gatchalian ,Yuria Maricich ,Charles Ruetsch Kathryn Anastassopoulos ,Bruce Imbert ,Benjamin Parcher ,Laura Kauffman ,Xiaorui Xiong ,Julia Strandberg ,Stephen Braun ,Lisaa Marsch ,Hilaryf Luderer ,Curtisf Corl ,Charles Ruetsch Yuri Maricich ,Sam Colman ,Tripp Wylie ,Alice Kuo ,Fultonf Velez ,Nicole Gellings Lowe ,Us Centers For Disease ,Journal Of Current Medical Research ,Expert Review Of Pharmacoeconomics Outcomes Research ,Software Precertification Pilot Program ,Nasdaq ,Journal Of Market Access Health ,Pear Therapeutics Us Inc ,Corporate Communications ,Pear Therapeutics Inc ,Current Medical Research ,Pear Therapeutics ,Disease Control ,Chief Commercial Officer ,Good Manufacturing Practice Compliant ,Safety Information ,Press Release ,Clinician Brief Summary ,Opioid Use Disorder ,Clinician Brief Summary Instructions ,Precertification Pilot ,Consult Clin ,Charles Ruetsch ,Kathryn Anastassopoulos ,Expert Review ,Outcomes Research ,Ali Jalali ,Medical Economics ,Jeffrey Botbyl ,Dylan Mezzio ,Postgraduate Medicine ,Yuri Maricich ,Cost Effectiveness Analysis ,Prescription Digital Therapeutic ,Market Access ,Health Policy ,Hospital Practice ,Business Wire ,